Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Agenus Inc. - Common Stock (NQ:AGEN)

4.855 +0.015 (+0.31%)
Streaming Delayed Price Updated: 9:40 AM EDT, Jul 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Agenus Inc. - Common Stock

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
42 Stocks Moving In Tuesday's Mid-Day Session
Gainers Agenus Inc. (NASDAQ: AGEN) shares surged 33.4% to $4.35. Bristol-Myers Squibb Co and Agenus entered into a global exclusive license agreement, under which Bristol Myers... 
Via Benzinga
What's Going On With Agenus Stock Today?
Agenus Inc (NASDAQ:AGEN) shares are trading higher by 35.2... 
Via Benzinga
Mid-Morning Market Update: Markets Mixed; Walmart Tops Q1 Expectations
Following the market opening Tuesday, the Dow traded down 0.23% to 34,248.63 while the NASDAQ rose 0.39% to 13,431.72. The S&P also fell, dropping 0.13% to 4,158.02. The U.S.... 
Via Benzinga
Topics Stocks
Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge
Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name... 
Via Benzinga
Bristol Myers Inks $1.6B Licensing Agreement For Agenus' Bispecific Antibody Program In Solid Tumors
Bristol-Myers Squibb Co (NYSE: BMY) and Agenus Inc (NASDAQ: AGEN) have entered into a global exclusive license agreement, under which Bristol Myers will... 
Via Benzinga
Agenus and Bristol Myers Squibb Announce Exclusive Global License for Agenus’ Anti-TIGIT Bispecific Antibody Program
From Bristol-Myers Squibb
Via Business Wire
Why Agenus Stock Tumbled Today
The company announced mixed Q1 results on a day when many biotech stocks were sinking. 
Via The Motley Fool
Agenus Inc (AGEN) Q1 2021 Earnings Call Transcript
AGEN earnings call for the period ending April 30, 2021. 
Via The Motley Fool
Topics Earnings
The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 5) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.